EMOL Health Poster Presentation at NCCN

EMOL Health Poster Presentation at NCCN

EMOL Health Leadership had the opportunity to attend the NCCN 2025 Annual Conference and present the results of a study on Myelosuppression and Healthcare Utilization in Community Oncology Patients with Limited-Stage Small Cell Lung Cancer (LS-SCLC) Receiving...
EMOL Abstract Accepted for NCCN 2025

EMOL Abstract Accepted for NCCN 2025

EMOL Health, a data aggregation company for community oncology practices, Ajeet Gajra, MD, and Pharmacosmos (G1 Therapeutics) are proud to announce that their abstract has been accepted for presentation at the 2025 NCCN Annual Conference to be held in Orlando, March...